Chris Paquette of DeepIntent Named 2020 PM360 Trailblazer Vanguard Award Winner

PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Chris Paquette, Founder & CEO, DeepIntent as the 2020 Trailblazer Vanguard Award winner.  

Chris Paquette is Chief Executive Officer of DeepIntent, a marketing technology company he co-founded on the principle that digital media can influence positive health outcomes. MarketMatch®, the company’s healthcare technology platform, currently supports 20 major pharmaceutical companies and dozens of media agencies to advertise more than 200 healthcare brands.

“It is an honor for our work to be recognized with this prestigious award. Our mission to measurably improve patient outcomes through the artful combination of data and media is one that cannot be accomplished alone,” said Paquette. “Our clients, our partners, and the entire DeepIntent team have supported our relentless pursuit of this vision over the past four years, so I thank them for their continued belief in me and our company.”

Since 2009, the PM360 Trailblazer Awards have recognized outstanding achievement and innovation in healthcare marketing. Each year, nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts. The Vanguard Award is given to an industry pioneer who developed a new service, strategy, product, or technology that greatly impacted the industry.  

“Even as programmatic advertising was rapidly being adopted by other industries, marketers were still hesitant to embrace this new technology. But Chris’ innovation went a long way towards changing that,” says Anna Stashower, CEO and Publisher of PM360. “In developing a healthcare-specific programmatic platform, Chris offered the marketers in our industry the security, speed, and scale they were waiting for. Now, programmatic has become a key tool for our industry, and its use is only growing.”   

In total, 47 winners were honored during a virtual awards ceremony on October 1, 2020. The winners will be featured in the October issue of PM360 and on www.pm360online.com.  

#  #  #

About PM360

PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.

The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.

By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.

Contact us to learn more

More News

Taboola DeepIntent
Press Release
Taboola Teams with DeepIntent, Empowering More Pharma Advertisers to Reach Massive Scale on Premium Publishers
NEW YORK, September 11, 2023 — Taboola (Nasdaq: TBLA), a global leader in powering recommendations for the open web, today announced a new partnership...
Read More
Introducing DeepIntent Copilot
Press Release
DeepIntent Launches DeepIntent Copilot, AI-Powered Recommendations and Insights to Usher in New Intelligent DSP
Leveraging unique connected datasets from across DeepIntent’s platform, DeepIntent Copilot provides actionable insights and recommendations focused on achieving healthcare-specific KPIs NEW YORK, September 11,...
Read More
Winner Digiday Media Awards
Press Release
DeepIntent Wins Digiday Media Award for Best Ad Tech Platform
Purposefully built for the pharmaceutical industry, the DeepIntent Healthcare Advertising Platform is proven to drive higher audience quality and script performance NEW YORK, June...
Read More